This company has been marked as potentially delisted and may not be actively trading. Histogenics (HSGX) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock HSGX vs. APT, MLSS, LGMK, AHPI, ANNA, TECX, ETON, ITOS, RVNC, and VIGLShould you be buying Histogenics stock or one of its competitors? The main competitors of Histogenics include Alpha Pro Tech (APT), Milestone Scientific (MLSS), LogicMark (LGMK), Allied Healthcare Products (AHPI), AleAnna (ANNA), Tectonic Therapeutic (TECX), Eton Pharmaceuticals (ETON), iTeos Therapeutics (ITOS), Revance Therapeutics (RVNC), and Vigil Neuroscience (VIGL). Histogenics vs. Its Competitors Alpha Pro Tech Milestone Scientific LogicMark Allied Healthcare Products AleAnna Tectonic Therapeutic Eton Pharmaceuticals iTeos Therapeutics Revance Therapeutics Vigil Neuroscience Histogenics (NASDAQ:HSGX) and Alpha Pro Tech (NYSE:APT) are both small-cap surgical appliances & supplies industry companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, media sentiment, dividends and valuation. Is HSGX or APT more profitable? Alpha Pro Tech has a net margin of 6.99% compared to Histogenics' net margin of 0.00%. Alpha Pro Tech's return on equity of 6.70% beat Histogenics' return on equity.Company Net Margins Return on Equity Return on Assets HistogenicsN/A -34.96% 18.40% Alpha Pro Tech 6.99%6.70%5.76% Which has preferable earnings and valuation, HSGX or APT? Alpha Pro Tech has higher revenue and earnings than Histogenics. Histogenics is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHistogenicsN/AN/A-$8.64M-$0.79-1.29Alpha Pro Tech$58.18M0.89$4.19M$0.3712.84 Do insiders & institutionals hold more shares of HSGX or APT? 40.4% of Histogenics shares are owned by institutional investors. Comparatively, 22.7% of Alpha Pro Tech shares are owned by institutional investors. 19.7% of Histogenics shares are owned by company insiders. Comparatively, 15.0% of Alpha Pro Tech shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has more risk and volatility, HSGX or APT? Histogenics has a beta of 3.1, indicating that its share price is 210% more volatile than the S&P 500. Comparatively, Alpha Pro Tech has a beta of 0.32, indicating that its share price is 68% less volatile than the S&P 500. Does the media favor HSGX or APT? In the previous week, Alpha Pro Tech had 1 more articles in the media than Histogenics. MarketBeat recorded 1 mentions for Alpha Pro Tech and 0 mentions for Histogenics. Histogenics' average media sentiment score of 0.00 equaled Alpha Pro Tech'saverage media sentiment score. Company Overall Sentiment Histogenics Neutral Alpha Pro Tech Neutral SummaryAlpha Pro Tech beats Histogenics on 7 of the 11 factors compared between the two stocks. Get Histogenics News Delivered to You Automatically Sign up to receive the latest news and ratings for HSGX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HSGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSGX vs. The Competition Export to ExcelMetricHistogenicsSurgical Appliances & Supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$96.49M$27.19M$5.55B$9.40BDividend YieldN/AN/A3.75%4.03%P/E Ratio-1.2912.8428.0119.82Price / SalesN/A2.23432.8198.20Price / CashN/A12.8036.1658.27Price / Book-102.002.178.125.65Net Income-$8.64M-$5.31M$3.25B$257.91M Histogenics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSGXHistogenicsN/A$1.02+2.0%N/A-45.4%$96.49MN/A-1.2949APTAlpha Pro Tech1.1352 of 5 stars$4.83+1.0%N/A-18.8%$52.47M$58.18M13.05120News CoverageMLSSMilestone Scientific3.1226 of 5 stars$0.66-2.6%$1.25+88.7%-28.3%$51.98M$8.61M-9.4630News CoverageNegative NewsLGMKLogicMark0.137 of 5 stars$0.00+2.9%N/A-100.0%$2.02M$9.88M0.0020Gap UpAHPIAllied Healthcare ProductsN/AN/AN/AN/A$16K$27.05M0.00150Gap UpANNAAleAnnaN/A$5.35-8.4%N/AN/A$388.93M$1.42M-267.50N/AGap UpTECXTectonic Therapeutic3.0144 of 5 stars$20.61-0.8%$83.60+305.6%+33.9%$388.02MN/A-2.82120ETONEton Pharmaceuticals1.9482 of 5 stars$15.80+9.8%$29.67+87.8%+339.2%$385.90M$39.01M-87.7820Analyst RevisionGap UpHigh Trading VolumeITOSiTeos Therapeutics3.4077 of 5 stars$10.12+0.5%$15.86+56.7%-37.1%$385.42M$35M-3.3390RVNCRevance Therapeutics2.6681 of 5 stars$3.65flat$8.45+131.5%N/A$381.02M$234.04M-1.89500VIGLVigil Neuroscience3.7283 of 5 stars$8.02+0.4%$10.80+34.7%+114.1%$381.02MN/A-3.9140News Coverage Related Companies and Tools Related Companies APT Competitors MLSS Competitors LGMK Competitors AHPI Competitors ANNA Competitors TECX Competitors ETON Competitors ITOS Competitors RVNC Competitors VIGL Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSGX) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Histogenics Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Histogenics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HSGX Stock Alerts